Eli Lilly Shares Rise 3.41% as Sales Outlook Improves, EPS Guidance Falls
Eli Lilly shares climbed 3.41% to $1,420.53 at 1:10 p.m. ET on October 30 as investors weighed higher sales expectations against a lower earnings outlook.
Eli Lilly NYSE:LLY, the diabetes and obesity drugmaker, is raising the sales bar while absorbing a bigger research bill. Shares climbed 3.41% to $1,420.53 at 1:10 p.m. ET on October 30 as investors weighed stronger revenue expectations against a lower earnings outlook. Scotiabank raised its price t…